Applicant, as named in the Orange Book
Amarin Pharms
Next listed expiry: Vascepa on 28 Jun 2033. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Vascepa NDA 202057 · 2 strengths icosapent ethyl | 28 Jun 2033 patent, carve-out possible |
Recent events
- Vascepa · Generic approved · ANDA 218949, Aurobindo Pharma LtdApproved 24 Jun 2026Detected 25 Oct 2026